These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 1761460)

  • 1. Interference of cefpirome with the measurement of plasma creatinine.
    Kulkarni S; Wilson AP; Grüneberg RN; Filipiak C; Samuell CT
    J Antimicrob Chemother; 1991 Oct; 28(4):617-9. PubMed ID: 1761460
    [No Abstract]   [Full Text] [Related]  

  • 2. Positive interference with the Jaffé reaction by cefpirome.
    Kerr JR; Ferguson WP; Archbold P
    Intensive Care Med; 1997 Mar; 23(3):357-8. PubMed ID: 9083249
    [No Abstract]   [Full Text] [Related]  

  • 3. In vivo and in vitro positive interference by cefpirome in measurement of serum creatinine by the Jaffe method.
    Kaburaki J; Yamada M; Kamikawara M; Konosu Y; Iwase M; Uehara S; Kikuchi H
    Keio J Med; 1999 Jun; 48(2):93-6. PubMed ID: 10405525
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum creatinine assays in patients receiving the antibiotic Cefpirome (HR 810): a study of three different routine methods compared with a specific HPLC method.
    Legg EF; Guy JM
    Med Lab Sci; 1992 Dec; 49(4):248-51. PubMed ID: 1339927
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interference by the new antibiotic cefpirome and other cephalosporins in clinical laboratory tests, with special regard to the "Jaffé" reaction.
    Grötsch H; Hajdu P
    J Clin Chem Clin Biochem; 1987 Jan; 25(1):49-52. PubMed ID: 3559483
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Interference of cephalosporins on the serum creatinine estimation (author's transl)].
    Kanazawa T; Hayashi Y; Sato Y; Azuma Y
    Rinsho Byori; 1980; 28(6):583-7. PubMed ID: 7411977
    [No Abstract]   [Full Text] [Related]  

  • 7. In vivo and in vitro interference due to cefotaxime on the assay of creatinine.
    Mckendrick MW; Legg EF
    J Clin Pathol; 1981 Feb; 34(2):224-5. PubMed ID: 6262386
    [No Abstract]   [Full Text] [Related]  

  • 8. Relationship between cefpirome clearance, serum creatinine, weight and age in patients treated for infection.
    Wilcox MH; Pithie A; Smith G; Moreland TA; Davey PG; Finch RG
    J Antimicrob Chemother; 1991 Aug; 28(2):291-9. PubMed ID: 1778859
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cefpirome clinical pharmacokinetics.
    Strenkoski LC; Nix DE
    Clin Pharmacokinet; 1993 Oct; 25(4):263-73. PubMed ID: 8261711
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Population pharmacokinetics and pharmacodynamics of cefpirome in critically ill patients against Gram-negative bacteria.
    Roos JF; Lipman J; Kirkpatrick CMJ
    Intensive Care Med; 2007 May; 33(5):781-788. PubMed ID: 17342515
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Susceptibility of Klebsiella spp. to cefpirome and cefepime.
    Tuchiluş C; Poiată A; Iancu LS; Bădicuţ I; Ambăruş A; Buiuc D
    Rev Med Chir Soc Med Nat Iasi; 2006; 110(2):465-7. PubMed ID: 17802963
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Activity of cefpirome (HR810) against Pseudomonas aeruginosa strains with characterised resistance mechanisms to beta-lactam antibiotics.
    Gargalianos P; Oppenheim BA; Skepastianos P; Livermore DM; Williams RJ
    J Antimicrob Chemother; 1988 Dec; 22(6):841-8. PubMed ID: 3149631
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Interaction of cephalosporines with creatinine in the blood and urine].
    Dauchy F; Coignet MC
    Nouv Presse Med; 1980 Nov; 9(41):3091-2. PubMed ID: 7443451
    [No Abstract]   [Full Text] [Related]  

  • 14. [In vitro antibacterial activity of a new cephalosporin: cefpirome (HR 810). Comparison with ceftriaxone, cefotaxime, latamoxef and ceftazidime].
    Le Noc P; Bryskier A; Le Noc D
    Pathol Biol (Paris); 1986 Jun; 34(5 Pt 2):567-71. PubMed ID: 3534744
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Extension of resistance to cefepime and cefpirome associated to a six amino acid deletion in the H-10 helix of the cephalosporinase of an Enterobacter cloacae clinical isolate.
    Barnaud G; Labia R; Raskine L; Sanson-Le Pors MJ; Philippon A; Arlet G
    FEMS Microbiol Lett; 2001 Feb; 195(2):185-90. PubMed ID: 11179650
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In-vitro antimicrobial activity of Cefpirome: a new fourth-generation cephalosporin against clinically significant bacteria.
    Hafeez S; Izhar M; Ahmed A; Zafar A; Naeem M
    J Pak Med Assoc; 2000 Aug; 50(8):250-2. PubMed ID: 10992706
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cefpirome. A review of its antibacterial activity, pharmacokinetic properties and clinical efficacy in the treatment of severe nosocomial infections and febrile neutropenia.
    Wiseman LR; Lamb HM
    Drugs; 1997 Jul; 54(1):117-40. PubMed ID: 9211085
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cefpirome susceptibility in staphylococci isolates.
    Poiată A; Tuchiluş C; Bădicuţ I; Buiuc D
    Rev Med Chir Soc Med Nat Iasi; 2007; 111(1):276-9. PubMed ID: 17595881
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interference of selected second- and third-generation cephalosporins with creatinine determination.
    Guay DR; Meatherall RC; Macaulay PA
    Am J Hosp Pharm; 1983 Mar; 40(3):435-8. PubMed ID: 6846351
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Activity of fourth generation cephalosporins against clinical isolates of Enterobacteriaceae].
    Tuchiluş C; Poiată A; Bădicuţ I; Teodor A; Luca V; Grigore L; Buiuc D
    Rev Med Chir Soc Med Nat Iasi; 2003; 107(3):595-8. PubMed ID: 14756068
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.